Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Zalcberg

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Anti-Cancer Drugs|August 1, 1997
Overview of the tolerability of 'Tomudex' (raltitrexed): collective clinical experience in advanced colorectal cancerJ Zalcberg
Pharmacology|December 31, 1997
In vitro binding of MX2 (KRN8602) and epirubicin to human plasma proteinW Z Zhang, W Cosolo, J Zalcberg
Biotechniques|June 22, 1999
Absolute quantitation of MDR1 transcripts using heterologous DNA standards--validation of the competitive RT-PCR (CRT-PCR) approachA el-Osta, P Kantharidis, J Zalcberg
Investigational New Drugs|April 1, 1992
Phase II study of 10-EdAM in patients with squamous cell carcinoma of the head and neck, previously untreated with chemotherapyM D Green, P Sherman, J Zalcberg
European Journal of Cancer (Oxford, England : 1990)|February 19, 1999
Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Tomudex International Study GroupJ Zalcberg, D Kerr, L Seymour, et al.
Asia-Pacific Journal of Clinical Oncology|June 17, 2025
A New Dawn-Using Teletrials for Early Phase Drug Development: A Practical GuidelineG Gaughran, J Zalcberg, M Voskoboynik, et al.
Cancer|July 15, 1995
Impaired cell-mediated immunity of apparently normal patients who had multiple skin cancersD Czarnecki, J Zalcberg, E Kulinskáya, et al.
Immunology and Cell Biology|June 1, 1990
Characteristics of a breast cancer-associated antigen defined by RCC-1 antibodyJ J Tjandra, J Zalcberg, P X Xing, et al.
ANZ Journal of Surgery|March 22, 2002
Training general practitioners in flexible sigmoidoscopy to screen for colorectal cancerJ A Martin, B Crotty, D Barbaro, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1992
Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivoD J Morgan, Y McCormick, W Cosolo, et al.
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Anti-Cancer Drugs|August 1, 1997
Overview of the tolerability of 'Tomudex' (raltitrexed): collective clinical experience in advanced colorectal cancerJ Zalcberg
Pharmacology|December 31, 1997
In vitro binding of MX2 (KRN8602) and epirubicin to human plasma proteinW Z Zhang, W Cosolo, J Zalcberg
Biotechniques|June 22, 1999
Absolute quantitation of MDR1 transcripts using heterologous DNA standards--validation of the competitive RT-PCR (CRT-PCR) approachA el-Osta, P Kantharidis, J Zalcberg
Investigational New Drugs|April 1, 1992
Phase II study of 10-EdAM in patients with squamous cell carcinoma of the head and neck, previously untreated with chemotherapyM D Green, P Sherman, J Zalcberg
European Journal of Cancer (Oxford, England : 1990)|February 19, 1999
Haematological and non-haematological toxicity after 5-fluorouracil and leucovorin in patients with advanced colorectal cancer is significantly associated with gender, increasing age and cycle number. Tomudex International Study GroupJ Zalcberg, D Kerr, L Seymour, et al.
Asia-Pacific Journal of Clinical Oncology|June 17, 2025
A New Dawn-Using Teletrials for Early Phase Drug Development: A Practical GuidelineG Gaughran, J Zalcberg, M Voskoboynik, et al.
Cancer|July 15, 1995
Impaired cell-mediated immunity of apparently normal patients who had multiple skin cancersD Czarnecki, J Zalcberg, E Kulinskáya, et al.
Immunology and Cell Biology|June 1, 1990
Characteristics of a breast cancer-associated antigen defined by RCC-1 antibodyJ J Tjandra, J Zalcberg, P X Xing, et al.
ANZ Journal of Surgery|March 22, 2002
Training general practitioners in flexible sigmoidoscopy to screen for colorectal cancerJ A Martin, B Crotty, D Barbaro, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1992
Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivoD J Morgan, Y McCormick, W Cosolo, et al.
Pageof 7